Results for tag: "Gastrointestinal Disorder Drug"

The Gastrointestinal Disorder Drug market is composed of drugs used to treat a variety of gastrointestinal disorders, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. These drugs are used to reduce symptoms such as abdominal pain, diarrhea, and nausea, as well as to reduce inflammation and improve overall digestive health. Commonly prescribed drugs include antacids, proton pump inhibitors, antibiotics, and anti-inflammatory medications. In addition, probiotics, prebiotics, and dietary supplements are also used to treat gastrointestinal disorders. Some of the major companies in the Gastrointestinal Disorder Drug market include AbbVie, AstraZeneca, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novartis, Pfizer, and Takeda Pharmaceuticals. Show Less Read more